Skip to content

Breath, sputum, serum and urine analysis for the diagnosis of tuberculosis; characterisation of volatile biomarkers for TB

Breath, sputum, serum and urine analysis for the diagnosis of tuberculosis; characterisation of volatile biomarkers for TB - BiomarkTB

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON31089
Enrollment
85
Registered
2007-10-31
Start date
2007-11-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

TB tuberculosis

Interventions

None listed

Sponsors

Koninklijk Instituut voor de Tropen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients suspected of having TB. Some of these will be ZN positive and later confirmed by a positive M. tuberculosis culture; these will be the confirmed TB patients. The Non-TB patients will have a negative Ziehl-Neelsen (ZN) and a negative sputum culture for M. tuberculosis. For Children we will use ZN positive patients or culture positive patients or clinical and epidemiological evidence (family member with active TB) of TB and response to anti TB treatment. The non TB children are initially suspected for having TB but were later found to have another disease.;Cough for more than two weeks Weight loss abnormal chest x ray chest infection suspected For those under 18 years old, able to voluntarily give a urine specimen

Exclusion criteria

Exclusion criteria: Patients unable to understand nature of study and so unable to give proper informed consent

Design outcomes

Primary

MeasureTime frame
The GC-MS and PTR-MS VOC profiles will be anlysed by statistical methods e.g. principal component anlysis, linear discriminant function analysis (DFA), Partial least square (PLS) analysis. and artificial neural networ. The smell profiles of the electronic nose will be analysed in the same way as the GC-MS VOC profiles. The outcome will be a set of VOCs characteristic for tuberculosis. Part of the VOCs will be derived from the mycobacteria and part from the host. Perhaps the host VOCs can divided in infection disease related and TB specific VOCs.

Secondary

MeasureTime frame
N.A.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)